<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>age-specific immunotherapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/age-specific-immunotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 15 Sep 2025 19:19:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>age-specific immunotherapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>New Review Advocates Age-Specific Immunotherapy Approaches for Childhood Brain Tumors</title>
		<link>https://bioengineer.org/new-review-advocates-age-specific-immunotherapy-approaches-for-childhood-brain-tumors/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 15 Sep 2025 19:19:04 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[age-specific immunotherapy]]></category>
		<category><![CDATA[immune evasion in tumors]]></category>
		<category><![CDATA[immunosuppressive tumor microenvironment]]></category>
		<category><![CDATA[pediatric brain tumors]]></category>
		<category><![CDATA[pediatric glioma immunotherapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-review-advocates-age-specific-immunotherapy-approaches-for-childhood-brain-tumors/</guid>

					<description><![CDATA[Pediatric brain tumors remain one of the deadliest and most challenging forms of childhood cancer, presenting distinctive biological characteristics that render many conventional treatment modalities ineffective. Unlike adult brain tumors, these malignancies showcase unique behaviors at the cellular and molecular levels, necessitating a fundamentally different therapeutic approach. A recent systematic review published in Neuro-Oncology Advances [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">269331</post-id>	</item>
	</channel>
</rss>
